Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass

被引：0

作者：

McClung, M. R. ^{[1
]}

Bolognese, M. A. ^{[2
]}

Brown, J. P. ^{[3
,4
]}

Reginster, J-Y ^{[5
]}

Langdahl, B. L. ^{[6
]}

Ruiz-Santiago, N. ^{[7
]}

Shi, Y. ^{[7
]}

Rojeski, M. ^{[7
]}

Timoshanko, J. ^{[8
]}

Libanati, C. ^{[8
]}

Kassahun, H. ^{[7
]}

Oates, M. ^{[7
]}

机构：

[1] Oregon Osteoporosis Ctr, Portland, OR USA

[2] Bethesda Hlth Res Ctr, Bethesda, MD USA

[3] Laval Univ, Quebec City, PQ G1K 7P4, Canada

[4] CHU Quebec CHUL, Res Ctr, Quebec City, PQ, Canada

[5] Univ Liege, Liege, Belgium

[6] Aarhus Univ Hosp, Aarhus, Denmark

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

[8] UCB Pharma, Anderlecht, Belgium

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2020年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-642

引用

页码：246 / 247

页数：2

共 50 条

[41] Effects of 2 Years of Treatment With Romosozumab Followed by 1 Year of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density.
McClung, M. R.
Chines, A.
Brown, J. P.
Diez-Perez, A.
Resch, H.
Caminis, J.
Bolognese, Ma
Goemaere, S.
Bone, H. G.
Zanchetta, J. R.
Maddox, J.
Rosen, O.
Bray, S.
Grauer, A.
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S53 - S53
[42] Effect of Teprenone (GGA) with Etidronate(EHDP) on lumbar bone mineral density in postmenopausal women with low bone mineral density
Shintani, M
Beppu, K
Hara, Y
BONE, 2003, 32 (05) : S209 - S209
[43] Changes in Lumbar Spine QCT, DXA, and TBS in Postmenopausal Women With Low Bone Mass Treated With Denosumab, Alendronate, or Placebo
Thomas, Thierry
Cheung, Angela M.
Shane, Elizabeth
Zanchetta, Jose R.
Kearns, Ann
Hans, Didier
Lin, Celia J. F.
Austin, Matthew
Libanati, Cesar
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
[44] Effects of 2 Years of Treatment with Romosozumab Followed By 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density.
McClung, M. R.
Chines, A.
Brown, J. P.
Diez-Perez, A.
Resch, H.
Caminis, J.
Bolognese, M. A.
Goemaere, S.
Bone, H. G.
Zanchetta, J. R.
Maddox, J.
Rosen, O.
Bray, S.
Grauer, A.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S406 - S407
[45] BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH HIP OSTEOARTHRITIS
Grygorieva, N.
Povoroznyuk, V.
Krochak, S.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1068 - 1068
[46] Bone mineral density in postmenopausal women with hip osteoarthritis
Grygorieva, N.
Povoroznyuk, V.
Krochak, S.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 36 - 37
[47] The rank ligand inhibitor denosumab (AMG 162) increases bone mineral density in postmenopausal women with low bone mass after 2 years of treatment
Lewiecki, E. M.
Miller, P. D.
McClung, M. R.
Cohen, S. B.
Lu, Y.
Wang, A.
Fitzpatrick, L. A.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 80 - 80
[48] Treatment With Monthly Romosozumab Injections Increases Areal Bone Mineral Density at the Lumbar Spine and Hip in Women With Chronic Spinal Cord Injury
Edwards, W. Brent
Crack, Laura E.
Muresan, Tudor
Simonian, Narina
Schnitzer, Thomas J.
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 271 - 272
[49] Treatment With Monthly Romosozumab Injections Increases Areal Bone Mineral Density at the Lumbar Spine and Hip in Women With Chronic Spinal Cord Injury
Edwards, W. Brent
Crack, Laura E.
Muresan, Tudor
Simonian, Narina
Schnitzer, Thomas J.
JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 19 - 19
[50] Exercises aimed to maximize lean mass and bone mineral density at the hip and lumbar spine
Nguyen, Vu H.
OSTEOPOROSIS AND SARCOPENIA, 2021, 7 (01) : 42 - 43

← 1 2 3 4 5 →